Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Tianyin Pharma Given SFDA OK to Launch Constipation Drug

publication date: Dec 22, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Tianyin Pharmaceutical received a production license for Tongbianling Capsules, a generic TCM treatment for constipation, in a dosage of 0.25 gram/capsule. The company plans to launch the new product in February 2009. Tianyin Pharma said constipation is a common problem among China’s elderly population: about 45 million Chinese use laxatives regularly. Tianyin, which operates on a June 30 fiscal year, also reiterated its fiscal year 2009 guidance. More details...

Stock Symbol: (NYSE Alternext: TPI)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners